Minal Dilip Desai

Minal Dilip Desai

Active Director Director DIN 02294917
DIN 02294917 First appointment Sep 2011 Primary industry Business Outsourcing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 11 active board seats
Past companies 5 historical roles
Total affiliations 16 Since Sep 2011
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 02 Sep 2011
Active appointments 12
Total timeline records 16

Minal Dilip Desai (DIN 02294917) has 16 recorded board appointments in Indian companies, the first from September 2011, of which 12 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2011
Dhc Global Technologies Private Limited Director · 2023 – present
Current
Rraynex Pharmaceuticals Private Limited Additional Director · 2023 – present
Current
Rynish Pharmaceuticals Private Limited Director · 2022 – present
Current
Current
Minal D. Desai Advisory Llp Designated Partner · 2020 – present
Current
Desai Haribhakti Consulting Private Limited Director · 2019 – present
Current
Dhr Advisors Private Limited Additional Director · 2019 – present
Current
Dhc International Private Limited Director · 2012 – present
Current
Dbd Investments Limited Director · 2011 – present
Current
Arihant Realcon Private Limited Director · 2011 – present
Current
Desai Infracon Private Limited Director · 2011 – present
Current
Dbd Realty Private Limited Director · 2011 – present
Current
Hb Advisory Services Private Limited Director · 2012 – 2013
Previous
Dbd Consulting Private Limited Director · 2011 – 2022
Previous
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available